Vasopeptidase Inhibitors

DBCAT004987Pharmacologic class

A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of... A DrugBank category of 3 drugs.

Drugs: Gemopatrilat
Omapatrilat
Sampatrilat

What you can answer from here — as of July 18, 2019

3DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

Which targets do Vasopeptidase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account